OAM
IRMD icon

Oppenheimer Asset Management’s iRadimed IRMD Stock Holding History

Oppenheimer Asset Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,265
Closed -$48K – 1254
2020
Q1 		$48K Sell
2,265
-26
-1% -$619 ﹤0.01% 1269
2019
Q4 		$54K Sell
2,291
-3
-0.1% -$70 ﹤0.01% 1328
2019
Q3 		$48K Sell
2,294
-20
-0.9% -$408 ﹤0.01% 1350
2019
Q2 		$47K Sell
2,314
-395
-15% -$9.3K ﹤0.01% 1382
2019
Q1 		$76K Buy
+2,709
New +$70.9K ﹤0.01% 1283

Other funds holding IRMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Oppenheimer Asset Management's IRMD Position: Q2 2020 in Review

Oppenheimer Asset Management sold out of iRadimed (IRMD) in Q2 2020, closing a stake of 2,265 shares — an estimated $48K sold.

Oppenheimer Asset Management first reported a position in IRMD in Q1 2019 and held it in 5 quarters. The position peaked at $76K in Q1 2019. 65 funds tracked by Wall St. Rank hold IRMD as of Q2 2020.

  • Oppenheimer Asset Management reported no remaining iRadimed position as of Q2 2020 after selling out during the quarter.
  • Oppenheimer Asset Management sold 2,265 iRadimed shares in Q2 2020, an estimated $48K.
  • Oppenheimer Asset Management first reported a position in iRadimed in Q1 2019 and held it in 5 quarters.
  • Oppenheimer Asset Management's iRadimed position peaked at $76K in Q1 2019.
  • 65 funds tracked by Wall St. Rank held iRadimed as of Q2 2020.

Based on Oppenheimer Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.